1201P Evaluation of efficacy TEMCAP regiment as first-line or further line therapy in patients with advanced, unresectable, progressive GEP-NET. Real-world data

Autor: Kolasinska-Cwikla, A.D., Cwikla, J., Palucki, J., Kawecki, M.A., Marcisz-Grzanka, K., Roszkowska-Purska, K., Jakubowicz, K., Chrapowicki, E., Wyrwicz, L.S.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S708-S708
Databáze: ScienceDirect